This Week at FDA: PDUFA VII guidance, COVID strain selection meeting, and more

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, FDA issued new guidance on its Prescription Drug User Fee Amendments (PDUFA VII) program…

Source: www.raps.org – Read more